SLX1 silencing overcomes Olaparib resistance in metastatic castration-resistant prostate cancer by disrupting SLX4-mediated DNA repair complexes by Xin Zhao, Shiyun Feng, Xiaoping Nitie, Shibu Muluo, Yi Lei

Subjects: “…mCRPC…”
Get full text

Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis by Sharath Kumar, Amit Joshi, Apurva Takke, Diana Varghese, Shruti Pathak, Vanita Noronha, Kumar Prabhash, Vikram Gota

Subjects: Get full text

Cabazitaxel-induced ureteritis in metastatic castration-resistant prostate cancer patients: a single center case series 2014–2024 by Ahmed H. Zedan, Jesper S. Gade, Karsten Egbert Arnold Zieger, Mads H. Poulsen, Anja Schmidt Vejlgaard, Filip Lund Hjorth Fredensborg

Subjects: Get full text

Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia by Moritz B. Bastian, Tilman Speicher, Arne Blickle, Caroline Burgard, Julius L. D. Bastian, Mark Bartholomä, Andrea Schaefer-Schuler, Stephan Maus, Samer Ezziddin, Florian Rosar

Subjects: Get full text

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER by A. A. Kostin, A. G. Muradyan, A. O. Tolkachev, S. V. Popov

Subjects: Get full text

Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis by Azka Syed, Hasan Raza, Hameer Khan Khaskheli, Izza Rafique, Sameen Shahid, Nimra Shahzadi, Abdelrahman Sayed Al Komi, Abdullah A. Assiri, Muhammad Abbas Khokhar, Najeeb Ullah Khan

Subjects: Get full text

Impact of interdisciplinary tumor boards (ITB) and personalized treatment on survival outcomes in metastatic castration-resistant prostate cancer by Laura Lawaczeck, Anna Rüdiger, Jörg Hennenlotter, Joël Hammes, Valentina Spingler, Simon Walz, Eva Erne, Igor Tsaur, Steffen Rausch

Subjects: Get full text

Study of predictive factors for response to 177LU-PSMA in patients with metastatic castration-resistant prostate cancer by Hugo Peslier, Valérie Seegers, Pierre-Alban Dufour

Subjects: Get full text

Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells by Karen A. Cavassani, Rebecca J. Meza, David M. Habiel, Jie‐Fu Chen, Alexander Montes, Manisha Tripathi, Gislâine A. Martins, Timothy R. Crother, Sungyong You, Cory M. Hogaboam, Neil Bhowmick, Edwin M. Posadas

Subjects: Get full text

Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure metastatic castration-res... by Zhiyu Zhang, Yanhang Yu, Chuanao Zhang, Jianglei Zhang, Xuefeng Zhang, Jun Ouyang

Subjects: “…metastatic castration-resistant prostate cancer (mCRPC)…”
Get full text

Editorial: Androgen-dependent diseases and their treatment by Marisa Cabeza

Subjects: “…metastatic castration-resistant prostate cancer (mCRPC)…”
Get full text

Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer by Maibritt Nørgaard, Maria Rusan, Karoline Kondrup, Ea Marie Givskov Sørensen, Simone Weiss, Marianne Trier Bjerre, Jacob Fredsøe, Søren Vang, Jørgen Bjerggaard Jensen, Bram De Laere, Henrik Grönberg, Michael Borre, Johan Lindberg, Karina Dalsgaard Sørensen

Subjects: “…Metastatic castration-resistant prostate cancer (mCRPC)…”
Get full text